Upcoming strategies in the treatment of non-small cell lung cancer stage IIIB/wet and IV;Neues in der behandlung des nicht-kleinzelligen bronchialkarzinoms im stadium IIIB (pleuraerguss) und IV

Wiener Medizinische Wochenschrift

Volumn 157, Issue 21-22, 2007, Pages 536-539

  Zabernigg, August ^a  

^a Abteilung fur Innere Medizin   (Austria)

Author keywords

Advanced; Metastatic; Non small cell lung cancer; Therapy

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; ERLOTINIB; GEMCITABINE; NAVELBINE; PEMETREXED; PROTEIN TYROSINE KINASE INHIBITOR;

CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; MAINTENANCE THERAPY; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE;

EID: 37349003904     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-007-0480-0     Document Type: Review

References (10)

1. Molina JR, Adjei AA, Jett JR (2006) Advances in chemotherapy of non-small cell lung cancer. Chest 130:1211-1219
2. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum, Johnson DH (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355: 2542-2550
3. Serke M, Kollmeier J (2007) Multimodale Therapie des kleinzelligen und nicht kleinzelligen Lungenkarzinoms. Dtsch Med Wochenschrift 132: 1221-1224
4. Manegold C, von Pawel J, Zatloukal P, Ramlau R, Gorbounova V, Hirsh V, Leighl N, Mezger J, Archer V, Reck M, the BO17704 study group (2007) Randomised, double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naïve patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC). ASCO Annual Meeting Proceedings Part I. J Clin Oncol 25: 18S (Suppl) LBA7514
5. Fidias P, Dakhi S, Lyss A, Loesch D, Waterhouse D, Cunneen J, Ye Z, Tai F, Obasaju C, Schiller J (2007) Phase III study of immediate versus delayed docetaxel after induction therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer: Updated report with survival. ASCO Annual Meeting Proceedings Part I. J Clin Oncol 25: 18S (Suppl) LBA7516
6. Merza T, Howard LM, Junagadhwalla M, Gajra A (2007) Exclusions to use of bevacizumab in elderly veterans with advanced non-small cell lung cancer (NSCLC). ASCO Annual Meeting Proceedings Part I. J Clin Oncol 25: 18S (Suppl) A18046
7. Agelaki S, Androulakis N, Agelidou A, Agelidou M, Kotsakis A, Kakolyris S, Polyzos A, Kentepozidis N, Ziras N, Mavroudis D (2007) Phase III randomized study of oral vinorelbine (oV) and gemcitabine (G) (oVG) versus docetaxel (D) and gemcitabine (DG) as first-line treatment of patients with advanced non-small cell lung cancer (NSCLC): A preliminary report. ASCO Annual Meeting Proceedings Part I. J Clin Oncol 25: 18S (Suppl) A7538
8. Grønberg BH, Bremnes R, Aasebø U, Brunsvig P, Fløtten Ø, Hjelde H, Wammer F, Stornes F, Tollåli T, Sundstrøm SH (2007) Pemetrexed + carboplatin versus gemcitabine + carboplatin in the treatment of stage IIIB/IV non-small cell lung cancer. ASCO Annual Meeting Proceedings Part I. J Clin Oncol 25: 18S (Suppl) A7517
9. Hesketh PJ, Chansky K, Wozniak AJ, Mack P, Lara PN, Franklin WA, Hirsch FR, Crowley J, Gandara DR (2007) Erlotinib as initial therapy in patients with advanced non-small cell lung cancer (NSCLC) and a performance status (PS) of 2: A SWOG phase II trial (S0341). ASCO Annual Meeting Proceedings Part I. J Clin Oncol 25: 18S (Suppl) A7536
10. Greco FA, Spigel DR, Burris HA, Shipley DL., Farley C, Gandhi J, Houston GA, Hainsworth JD (2007) Weekly docetaxel versus docetaxel/gemcitabine in elderly/poor performance status (PS) patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC): Randomized phase III trial of the Minnie Pearl Cancer Research Network. ASCO Annual Meeting Proceedings Part I. J Clin Oncol 25: 18S (Suppl) A7534